Your browser doesn't support javascript.
loading
Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2).
Gutic, Medo; Milosavljevic, Milos N; Safiye, Teodora; Milidrag, Ardea; Jankovic, Slobodan M.
Affiliation
  • Gutic M; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Milosavljevic MN; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Safiye T; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Milidrag A; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Jankovic SM; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Expert Rev Pharmacoecon Outcomes Res ; 23(5): 561-570, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36994735
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tripeptidyl-Peptidase 1 / Neuronal Ceroid-Lipofuscinoses Type of study: Health_economic_evaluation Aspects: Patient_preference Limits: Humans Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tripeptidyl-Peptidase 1 / Neuronal Ceroid-Lipofuscinoses Type of study: Health_economic_evaluation Aspects: Patient_preference Limits: Humans Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Country of publication: Reino Unido